Product Sales

The latest news about Product Sales: headlines, AI summaries and the full story from every source.

• Ionis Lowers TRYNGOLZA Revenue Guidance and Delays Cash Flow Breakeven to 2029 Motley Fool · November 9, 2026, 23:53 UTC
• Ionis Reports Q3 2026 Revenue Growth Driven by DAWNZERA Amid TRYNGOLZA Launch Adjustments Motley Fool · November 9, 2026, 23:24 UTC
• Puma Biotechnology Reports Q3 2026 Results with Revenue Growth Amidst China Royalty Reductions Motley Fool · November 6, 2026, 17:13 UTC
• Vera Therapeutics Reports Q3 2026 Results Following TRUTAKNA Commercial Launch Motley Fool · November 6, 2026, 06:41 UTC
• Legacy Housing Reports Significant Q3 2026 Revenue and Net Income Growth Motley Fool · November 5, 2026, 21:16 UTC
• BeOne Medicines Reports Strong Q3 2026 Results and Raises Full-Year Revenue Guidance Motley Fool · November 5, 2026, 20:58 UTC
• Acadia Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by DAYBUE and NUPLAZID Motley Fool · November 5, 2026, 15:38 UTC
• Nuvation Bio Reports Q3 2026 Revenue of $45 Million Driven by IBTROZI Growth Motley Fool · November 5, 2026, 14:53 UTC
• Arcutis Biotherapeutics Reports Q3 Net Product Revenues of $143.9 Million and Provides 2026 Guidance Seeking Alpha · November 5, 2026, 04:16 UTC
• Cricut Shares Surge 50% Following Strong Third Quarter Earnings Beat Motley Fool · November 4, 2026, 19:13 UTC
• Mirum Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by LIVMARLI Motley Fool · November 4, 2026, 15:09 UTC
• Alkermes Reports Q3 2026 Results with Strong Proprietary Product Growth Motley Fool · November 3, 2026, 21:08 UTC
• Axsome Therapeutics Reports Strong Q3 2026 Results Driven by AUVELITY Growth Motley Fool · November 2, 2026, 16:38 UTC
• Supernus Pharmaceuticals Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance Motley Fool · October 30, 2026, 15:24 UTC
• PTC Therapeutics Reports Record Q3 2026 Revenue and Raises Full-Year Guidance Motley Fool · October 30, 2026, 14:40 UTC
• Gilead Sciences Reports Strong Q3 2026 Results Driven by HIV and Oncology Growth Motley Fool · October 30, 2026, 14:09 UTC
• Vanda Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by Fanapt and NEREUS Motley Fool · October 29, 2026, 05:24 UTC
• NVE Reports Q1 2027 Earnings with Strong Revenue Growth Motley Fool · July 23, 2026, 00:55 UTC
• Axsome Therapeutics Reports Q1 2025 Earnings with Strong Revenue Growth Motley Fool · May 4, 2026, 15:15 UTC
• Axsome Therapeutics Reports Strong Q2 2025 Earnings with Revenue Growth Motley Fool · May 4, 2026, 15:15 UTC
• Butterfly (BFLY) Reports Q1 2026 Earnings with Revenue Growth and Improved Margins Motley Fool · May 1, 2026, 13:51 UTC
• Merck Reports Q1 2026 Earnings with Revenue Growth and Product Performance Highlights Motley Fool · April 30, 2026, 18:00 UTC
• Bristol Myers Squibb Reports Q1 2026 Earnings with Mixed Revenue Performance Motley Fool · April 30, 2026, 16:18 UTC
• Eli Lilly Reports Strong Q1 2026 Earnings with Revenue Growth Driven by Key Products Motley Fool · April 30, 2026, 15:31 UTC
• Ionis (IONS) Reports Q1 2026 Earnings with Strong Revenue Growth and Raised Guidance Motley Fool · April 29, 2026, 16:23 UTC
• Regeneron Shares Fall After Q1 Earnings Beat and New Repurchase Program Yahoo Finance · April 29, 2026, 14:12 UTC
• Incyte Reports Q1 2026 Earnings Results with Revenue Growth and Key Product Performance Motley Fool · April 28, 2026, 16:47 UTC
• BSX Reports Q2 2025 Earnings with Strong Revenue Growth and Margin Expansion Motley Fool · April 22, 2026, 14:54 UTC
• Blackbaud Reports Q3 2025 Earnings with Revenue Growth and Margin Decline Motley Fool · April 21, 2026, 15:42 UTC
• Ionis (IONS) Reports Q4 2025 Earnings with Revenue Growth and Guidance on TRYNGOLZA Motley Fool · April 21, 2026, 15:20 UTC